The tumor samples of PR-negative (P < 0.001, Fig. 8F), ER-negative (P < 0.001, Fig. 8G), or HER2-positive (P < 0.001, Fig. 8H) also possessed higher IGF2BP1 levels. Here, IGF2BP1 is linked to neoplasm.